Identifying and Caring for Individuals With Inherited Cancer Syndrome
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
This trial examines approaches to identify and care for individuals with inherited cancer syndrome. The purpose of this study is to offer no cost genetic testing to the general public. Researchers hope to learn the value of providing broad, public-wide testing for high risk cancer types (like hereditary breast and ovarian cancer or Lynch syndromes) instead of only testing people whose families are known to be high risk.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Wiek 18 lat lub więcej
- •W przeszłości (1-5 lat) otrzymano poradę genetyczną
- •Posiadanie mutacji genetycznych BRCA1, BRCA2 lub zespołu Lyncha
- •Aktualnie lub w przeszłości zdiagnozowany nowotwór
- •Możliwość utworzenia bezpiecznego konta aplikacji HOP
- •Zgoda na uczestnictwo w badaniu
- •Zgoda na pobranie próbki DNA
- •Wizyta w placówce medycznej w ciągu ostatniego roku
✗ Disqualifies
- •Uczestnictwo w poprzedniej fazie badania (Grupa A)
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- July 14, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (2)
Providence Portland Medical Center
Portland, United States
OHSU Knight Cancer Institute
Portland, United States
Trial contact
Bill J. Wright, Ph.D.
Bill J. Wright, Ph.D.
PRINCIPAL_INVESTIGATOR
Jackilen Shannon, Ph.D.
Jackilen Shannon, Ph.D.
PRINCIPAL_INVESTIGATOR
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/15/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.